Valens Semiconductor Ltd (NYSE:VLN)’s traded shares stood at 0.69 million during the last session, with the company’s beta value hitting 0.44. At the close of
Prelude Therapeutics Inc (NASDAQ:PRLD)’s traded shares stood at 0.3 million during the last session, with the company’s beta value hitting 1.48. At the close of
Werewolf Therapeutics Inc (NASDAQ:HOWL)’s traded shares stood at 0.34 million during the last session, with the company’s beta value hitting 0.30. At the close of
Coeptis Therapeutics Holdings Inc (NASDAQ:COEP)’s traded shares stood at 0.43 million during the last session, with the company’s beta value hitting -0.90. At the close
B. Riley Financial Inc (NASDAQ:RILY)’s traded shares stood at 0.85 million during the last session, with the company’s beta value hitting 1.24. At the close
Zenas Biopharma Inc (NASDAQ:ZBIO)’s traded shares stood at 0.46 million during the last session. At the close of trading, the stock’s price was $10.85, to
Wave Life Sciences Ltd (NASDAQ:WVE)’s traded shares stood at 0.74 million during the last session, with the company’s beta value hitting -1.13. At the close
Keros Therapeutics Inc (NASDAQ:KROS)’s traded shares stood at 0.49 million during the last session, with the company’s beta value hitting 1.20. At the close of
NioCorp Developments Ltd (NASDAQ:NB)’s traded shares stood at 0.41 million during the last session, with the company’s beta value hitting 0.16. At the close of
BIT Mining Ltd ADR (NYSE:BTCM)’s traded shares stood at 0.74 million during the last session, with the company’s beta value hitting 2.56. At the close
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
